Navigation Links
Chemist to donate potential pharmaceutical royalties to Madagascar
Date:11/12/2008

Blacksburg, Va. -- The National Institutes of Health has renewed a five-year research grant for a total of $2.5 million to an international biodiversity group lead by David G.I. Kingston, University Distinguished Professor of Chemistry at Virginia Tech.

Kingston is known internationally for his work in biodiversity and development of naturally occurring cancer-fighting agents. Consistent with the Convention on Biological Diversity, he will share a portion of any royalties generated by sales of pharmaceuticals developed from this work with Madagascar, the country in which the research is taking place.

The award is the third competitive renewal of a research program that Kingston began in 1993. The grant was accompanied by a companion award for the United States Department of Agriculture of $1.25 million over the next five years.

The overall goals of the International Cooperative Biodiversity Group are to foster biodiversity conservation, economic development, and drug discovery in Madagascar. The proposed research integrates the work of eight different research groups, located in the United States and around the world.

Kingston will lead a group at Virginia Tech that will focus on biodiversity in the areas of cancer and malaria. Other research groups will focus on immunology, neurological disease, and agrochemistry. Madagascar is home to 5 percent of the world's plant and animal species, of which more than 80 percent are endemic to the region. This makes it a rich source of material for the team to screen for compounds with natural product activity of possible interest and value.

"The first naturally occurring anticancer drugs were isolated from the Madagascar periwinkle," Kingston said. "It is our hope that we can find new anticancer agents from the country's plants, microbes, or marine organisms so that we can provide a benefit to cancer patients as well as reward Madagascar for preserving its biodivers
'/>"/>

Contact: Catherine Doss
cdoss@vt.edu
540-231-5035
Virginia Tech
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Biochemistry of human physiology in health and disease is focus of updated clinical text
2. JHU chemists devise self-assembling organic wires
3. The Camille & Henry Dreyfus Foundation to host important symposium on chemistry and the environment
4. Volcanoes may have provided sparks and chemistry for first life
5. Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist
6. Research center to free chemistry from Earths bonds
7. UC Riverside biochemists devise method for bypassing aluminum toxicity effects in plants
8. Computational biochemist uncovers a molecular clue to evolution
9. Smoke smudges Mexico Citys air, chemists identify sources
10. Biochemists manipulate fruit flavor enzymes
11. Food, health get top billing at national chemistry meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chemist to donate potential pharmaceutical royalties to Madagascar
(Date:7/30/2014)... biologists, led by Clemson University associate professor Andrew S. ... will pave the way for novel anti-fouling paint for ... and industrial applications. , The team,s findings, published in ... larval stage of barnacles that attaches to a wide ... material that acts as an underwater heavy-duty adhesive. , ...
(Date:7/30/2014)... Portland Press Limited today announced an across-the-board increase ... , The 2013 InCites Journal Citation Reports (Thomson ... Biochemical Journal , Essays in Biochemistry ... Bioscience Reports all received increases in their ... Biochemical Society and published by Portland Press Limited. ...
(Date:7/30/2014)... A professor from Wayne State University,s College of ... National Science Foundation for the project, "Nanoparticle-directed synthesis ... National Science Foundation, nanotechnology is the creation and ... novel properties and functions. A major bottleneck in ... methods that connect different functional materials into one ...
Breaking Biology News(10 mins):Study: Marine pest provides advances in maritime anti-fouling and biomedicine 2Across-the-board Impact Factor increases for Portland Press Limited 2NSF grant to Wayne State supports new concept for manufacturing nanoscale devices 2
... have created the first three-dimensional living tissue model, complete ... therapeutics to combat brain tumors. The 3-D model gives ... tissue cultures. The researchers created a glioma, or ... surrounds it. In a series of experiments, the team ...
... have succeeded in changing the genetic material of cancer ... in nanosurgery opens the door to new medical applications, ... A light scalpel to treat cancerous cells, The ... team uses a femtosecond laser (a laser with ultra-short ...
... Resolving the world,s major challenges whether climate change, ... scarcity requires a sweeping shift in our approach ... leading scientists told European policy makers today during ... and Societal Challenges for our Unstable Earth" (RESCUE). ...
Cached Biology News:Researchers make living model of brain tumor 2Europe needs a 'RESCUE' revolution 2Europe needs a 'RESCUE' revolution 3
(Date:7/30/2014)... (PRWEB) July 30, 2014 Sales Horizons, ... launch of blended sales training programs for companies engaged ... training programs used by thousands of salespeople over 25 ... sales training program can be customized to address the ... The blended sales training program consists of ...
(Date:7/30/2014)... Vycom announces the addition of Thermax PVC ... Factory Mutual (FM) 4910 fire propagation and smoke generation ... process tools, fume hoods, furniture and cabinetry. These criteria ... wafers used in electronic chip manufacturing. , ... excellent workability and superior aesthetics. It is available in ...
(Date:7/30/2014)... 30, 2014   Epic Sciences, Inc. ("Epic"), ... diagnostics to personalize and advance the treatment and management ... T. Lucier as chairman of Epic,s board of ... Life Technologies (formerly Invitrogen). Mr. Lucier joins Epic,s board ... circulating rare cell analysis platform with special focus on ...
(Date:7/30/2014)... 30, 2014 Vala Sciences was ... Environmental Protection Agency (EPA). This new contract was ... models, including tests designed to assess the effect ... formation of connections between neurons (synapses), which are ... synapse formation by environmental pollutants likely contributes to ...
Breaking Biology Technology:Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 2Sales Horizons Launches New Blended Sales Training Programs to Companies Engaged in Complex B2B Sales 3Vycom Announces Flametec® Thermax PVC (FM4910 Listed) For a Variety of Clean Room Applications with Excellent Workability and Aesthetics 2Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 2Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 3U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 2U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 3
... July 14 Bio-Optronics, Inc., a leader in healthcare workflow ... software solution that can simultaneously handle the most intricate scheduling ... staff schedules. , , Physician ... , Bio-Optronics President & CEO, ...
... , HALIFAX, NS, July 14 /PRNewswire/ - ImmunoVaccine ... entered into an agreement to exclusively license seven ... company. These proprietary antigens specifically target breast, ovarian ... antigens with its DepoVax(TM) delivery platform to develop ...
... , , TAMPA, Fla., July ... on the research and development of cancer immunotherapies, announces that the ... its dendritic cell therapy. , , ... I/II clinical trial testing the safety and efficacy of its immunotherapy ...
Cached Biology Technology:NEW Momentum(TM) Physician and Staff Scheduling Software for Imaging Centers, OB/GYN, and Other Specialty Practices Improves Productivity and Equity in Scheduling 2ImmunoVaccine Technologies Licenses Immunotope's Breast, Ovarian and Prostate Cancer Antigens 2Significant Milestone Marks the Beginning of FDA-Authorized Breast Cancer Trial 2Significant Milestone Marks the Beginning of FDA-Authorized Breast Cancer Trial 3